Last reviewed · How we verify

NCT05051111

Pre-stroke Physical Activity in Patients With Stroke

Completed Last updated 26 February 2024
What this trial tests

trial in Stroke in 123 participants. Completed in 31 December 2022.

Timeline
23 September 2021
Primary endpoint
21 February 2022
31 December 2022

Quick facts

Lead sponsorHerlev Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment123
Start date23 September 2021
Primary completion21 February 2022
Estimated completion31 December 2022
Sites1 location across Denmark

Conditions studied

Sponsor

Herlev Hospital

Who can join

18 and older, any sex, with Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to explore the level of pre-stroke physical activity in patients with stroke and to investigate associations between physical activity and sociodemographic variables, e.g. history of stroke, co-morbidities and subtype of stroke. Physical inactivity is a great risk factor for stroke; thus, the investigators hypothesise that patients hospitalised with stroke will present with a lower level of pre-stroke physical activity than recommended by World Health Organization (WHO) guidelines on physical activity for health. Additionally, the investigators expect to find an association between pre-stroke physical activity and specific sociodemographic variables, e.g. stroke subtype, and re-stroke.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Stroke

Currently open trials in the same condition.

Other Herlev Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05051111.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing